Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2014, Article ID 687257, 8 pages
http://dx.doi.org/10.1155/2014/687257
Clinical Study

Adalimumab Treatment in Biologically Naïve Crohn’s Disease: Relationship with Ectopic MUC5AC Expression and Endoscopic Improvement

Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan

Received 13 February 2014; Revised 22 March 2014; Accepted 24 March 2014; Published 16 April 2014

Academic Editor: Gerassimos Mantzaris

Copyright © 2014 Tsutomu Mizoshita et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Tsutomu Mizoshita, Satoshi Tanida, Hironobu Tsukamoto, et al., “Adalimumab Treatment in Biologically Naïve Crohn’s Disease: Relationship with Ectopic MUC5AC Expression and Endoscopic Improvement,” Gastroenterology Research and Practice, vol. 2014, Article ID 687257, 8 pages, 2014. https://doi.org/10.1155/2014/687257.